2U, Inc. Announces Date for 2023 Fourth Quarter and Full Year Earnings Report
2U, Inc. Announces Date for 2023 Fourth Quarter and Full Year Earnings Report
PR Newswire
LANHAM, Md., Feb. 1, 2024
LANHAM, Md., Feb. 1, 2024 /PRNewswire/ -- 2U, Inc. (Nasdaq: TWOU) announced today that it will report its fourth quarter and full year 2023 financial and operational results on Monday, February 12, 2024. Paul Lalljie, Chief Executive Officer, and Matthew Norden, Chief Financial Officer, will hold an audio webcast and conference call at 4:30 p.m. ET to discuss the results.
To pre-register, click here. To access the live webcast, visit investor.2u.com. To participate in the conference call by telephone from the U.S., dial 1-888-330-2446 (toll-free), or from outside the U.S., dial 1-240-789-2732 (toll), and provide conference ID number 1153388. A recording of the webcast will be posted to 2U's Investor Relations website as soon as it is available.
About 2U, Inc. (Nasdaq: TWOU)
2U is a global leader in online education. Guided by its founding mission to eliminate the back row in higher education, 2U has spent 15 years advancing the technology and innovation to deliver world-class learning outcomes at scale. Through its global online learning platform edX, 2U connects more than 81 million people with thousands of affordable, career-relevant learning opportunities in partnership with 250 of the world's leading universities, institutions, and industry experts. From free courses to full degrees, 2U is creating a better future for all through the power of high-quality online education. Learn more at 2U.com.
Investor Contact:
investorinfo@2u.com
Media Contact:
media@2u.com
SOURCE 2U, Inc.
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth